Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a condition related to Guillain-Barre syndrome that, in rare instances, may follow certain vaccinations.

Contact a Vaccine Injury Lawyer to Learn More About Filing CIDP Lawsuit

The nationwide law firm of Bernstein Liebhard LLP is now investigating potential
CIPD lawsuits involving the seasonal flu vaccine and other inoculations. If you or someone you love were diagnosed with CIDP, and you believe a vaccine could be to blame, please contact our office today by calling (888) 994-5118.

What is Chronic Inflammatory Demyelinating Polyneuropathy or (CIDP)?

CIDP is an autoimmune disorder that causes inflammation of nerves and nerve roots. This inflammation can destroy the myelin, or protective coating, around the nerves. Destruction of myelin can harm nerve fibers and slow the nerves’ ability to send signals.

CIDP is closely related to Guillain-Barre syndrome, or GBS. However, while most people with GBS will recover quickly with treatment, CIDP is usually a long-term problem. In some cases, people with GBS will go on to develop CIDP.

Signs and symptoms of CIDP include:

  • Muscle weakness, especially in the arms and legs, as well as the area around the hips and shoulders.
  • Sensory symptoms, such as numbness, burning, or tingling in the hands or feet.
  • Motor symptoms, such as lack of coordination or difficulty walking.
  • Fatigue
  • Difficulty swallowing
  • Double vision

Early treatment is the vital if a CIDP victim is to recover. Treatment usually involves repeated courses of either an intravenous immunoglobulin or plasma exchange.

Vaccines and CIDP

Guillain-Barre syndrome (GBS), a potential trigger for CIDP, has been linked to certain vaccines, including the flu vaccine and the HPV vaccine.

In fact, the National Vaccine Injury Compensation Program (NVICP) recognizes GBS as a covered injury for the seasonal flu vaccine. Since 2011, the program has also paid compensation to individuals who were diagnosed with GBS or CIDP following administration of the DTap and Tdap vaccines, as well as the meningitis vaccine.

Under the NVICP’s guidelines, a vaccine injury is presumed to be covered if:

  • The injury meets the definition included in the program’s Vaccine Injury Table.
  • The first symptom of the condition occurred within the time period specified by the table.

If an injury does not appear in the Vaccine Injury Table or does not meet the Table requirements, claimants must present expert witness testimony, medical records, medical opinions, or other evidence proving that the vaccine caused the injury and/or condition.

To date, the NVICP has paid more than $3.9 billion to people who have filed petitions for vaccine-related injuries.

Obtain a Free, No-Obligation Review of Your Case

Our firm is offering free, no-obligation legal reviews to individuals who developed symptoms of CIDP following vaccination. To discuss filing a CIDP lawsuit with a member of our legal team, please call (888) 994-5118.

Last Modified: July 3, 2018

Get the latest news and litigation updates about this case by following us on Facebook. Click the "Like" button below.


Follow Us on Google+ on Facebook on LinkedIn on Twitter on YouTube on Pinterest

Skip to content